Hand Eczema Market OverviewHand dermatitis, often known as hand eczema, is one of the most common types of eczema and one of the most common skin conditions worldwide. It mostly affects the palms, though it can also affect other parts of the hand.&nbsp; <a href="https://www.delveinsight.com/report-store/hand-eczema-epidemiology-forecast" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Hand Eczema Epidemiology</a> Insights (2021)The Total Hand Eczema prevalent cases in the 7MM were 63 million cases in 2021 Gender-specific Prevalent Cases of Hand Eczema in the US<ul><li>Males - 11 million</li><li>Females - 15 million</li></ul> Hand Eczema Epidemiology Segmentation in the 7MM from 2019 to 2032<ul><li>Total Prevalent Cases of Hand Eczema</li><li>Type-Specific Cases of Hand Eczema</li><li>Gender-Specific Cases of Hand Eczema</li><li>Severity-Specific Cases of Hand Eczema</li><li>Subgroup-Specific Cases of Hand Eczema</li></ul> <a href="https://www.delveinsight.com/report-store/hand-eczema-market" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Hand Eczema Market</a> InsightThe Hand Eczema Market size in the 7MM was valued USD 11 billion in 2021 Hand Eczema Market Strengths<ul><li>Development of disease-specific treatments and novel therapeutic drug classes such as</li><li>JAK inhibitors are likely to boost the market growth.</li></ul> Hand Eczema Market Opportunities<ul><li>The emerging drugs have a significant opportunity, as there are no disease-specific approved therapies for the treatment of hand eczema in the US.</li></ul> Hand Eczema Emerging Drugs and Key Companies<ul><li>Dupilumab: Regeneron/Sanofi</li><li>Delgocitinib: Leo Pharma/Japan Tobacco Inc.</li><li>Ruxolitinib cream: Incyte Corporation</li><li>ASN002 (Gusacitinib): Asana Biosciences, and others</li></ul>

Hand Eczema

Hand Eczema Market

Hand Eczema Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape